799841-02-4
799841-02-4
Chemical Structure
FR-229934
- CAS No.: 799841-02-4
- Formula:C21H23Cl2N3O3S
- Molecular Weight:468.40
IUPAC Name: 1-(3,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide
InChIKey: QLXVZAXTUBLQJW-UHFFFAOYSA-N
SMILES: O=C(C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C(Cl)=C3)C2=C1)NS(=O)(CCCCC)=O
Biological Activity: FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
FR-229934 | 99.66% | FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
FR-229934 (Standard) | ≥98% | FR-229934 (Standard) is the analytical standard of FR-229934 (HY-105686). This product is intended for research and analytical applications. FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
